Heidelberg Pharma AG
XMUN:HPHA
Heidelberg Pharma AG
XMUN:HPHA
Price:
2.73
EUR
Market Closed
Market Cap:
€127.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
I
|
Intuit Inc
DUS:ITU
|
US |
|
N
|
Note AB (publ)
XBER:NQA
|
SE |
|
S
|
SPS Finquest Ltd
BSE:538402
|
IN |
|
T
|
Toronto-Dominion Bank
LSE:0VL8
|
CA |
|
M
|
Mitsubishi UFJ Financial Group Inc
XHAM:MFZ
|
JP |
|
S
|
Sekisui House Ltd
XBER:SPH1
|
JP |
|
B
|
Bayer AG
SWB:BAYN
|
DE |
|
Roche Holding AG
SIX:RO
|
CH |
|
Banco Santander SA
F:BSDK
|
ES |
|
B
|
Bank of China Ltd
XMUN:W8V
|
CN |
|
O
|
Owens Corning
SWB:O5Q
|
US |
|
Anglo American PLC
LSE:AAL
|
UK |
|
B
|
Biogen Inc
LSE:0R1B
|
US |
|
Chow Tai Fook Jewellery Group Ltd
HKEX:1929
|
HK |
|
Renault SA
PAR:RNO
|
FR |
|
L
|
Liberty Global PLC
F:1LG
|
UK |
|
Nick Scali Ltd
F:NJN
|
AU |
|
W
|
Willscot Mobile Mini Holdings Corp
SWB:WS11
|
US |
|
Lovesac Co
NASDAQ:LOVE
|
US |
|
S
|
SM Prime Holdings Inc
XPHS:SMPH
|
PH |
|
G
|
Greenidge Generation Holdings Inc
NASDAQ:GREE
|
US |
|
Aedifica NV
XBRU:AED
|
BE |
|
F
|
Fastly Inc
SWB:2Y7
|
US |
Balance Sheet
Balance Sheet Decomposition
Heidelberg Pharma AG
Heidelberg Pharma AG
Balance Sheet Decomposition is not available for
Heidelberg Pharma AG
Heidelberg Pharma AG
Balance Sheet
Heidelberg Pharma AG
Heidelberg Pharma AG
Currency: EUR
| Nov-2015 | Nov-2016 | Nov-2017 | Nov-2018 | Nov-2019 | Nov-2020 | Nov-2021 | Nov-2022 | Nov-2023 | Nov-2024 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
1
|
5
|
30
|
19
|
10
|
5
|
6
|
81
|
43
|
29
|
15
|
|
| Cash Equivalents |
1
|
5
|
30
|
19
|
10
|
5
|
6
|
81
|
43
|
29
|
15
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
2
|
6
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
2
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
5
|
10
|
12
|
11
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
5
|
31
|
20
|
12
|
8
|
9
|
88
|
57
|
48
|
28
|
|
| PP&E Net |
1
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
4
|
3
|
1
|
|
| PP&E Gross |
1
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
4
|
3
|
1
|
|
| Accumulated Depreciation |
3
|
3
|
3
|
4
|
4
|
5
|
6
|
6
|
7
|
8
|
0
|
|
| Intangible Assets |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Goodwill |
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Assets |
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Total Assets |
12
N/A
|
15
+26%
|
41
+172%
|
31
-25%
|
23
-26%
|
20
-15%
|
22
+11%
|
101
+363%
|
70
-30%
|
61
-14%
|
38
-37%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
2
|
0
|
1
|
3
|
1
|
3
|
8
|
6
|
7
|
|
| Accrued Liabilities |
2
|
1
|
2
|
3
|
3
|
3
|
3
|
4
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
4
|
0
|
0
|
0
|
0
|
10
|
16
|
6
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
1
|
2
|
2
|
0
|
0
|
5
|
5
|
1
|
3
|
|
| Total Current Liabilities |
3
|
5
|
4
|
5
|
6
|
7
|
15
|
28
|
20
|
8
|
11
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
37
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
1
|
0
|
1
|
|
| Total Liabilities |
3
N/A
|
5
+109%
|
4
-19%
|
5
+19%
|
7
+26%
|
7
+0%
|
15
+123%
|
34
+126%
|
21
-38%
|
30
+42%
|
49
+64%
|
|
| Equity | ||||||||||||
| Common Stock |
9
|
13
|
22
|
28
|
28
|
31
|
34
|
47
|
47
|
47
|
47
|
|
| Retained Earnings |
184
|
191
|
202
|
213
|
222
|
240
|
266
|
285
|
302
|
321
|
363
|
|
| Additional Paid In Capital |
185
|
188
|
216
|
210
|
210
|
222
|
238
|
305
|
305
|
305
|
305
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
9
N/A
|
10
+3%
|
37
+279%
|
26
-30%
|
16
-37%
|
13
-21%
|
7
-48%
|
67
+895%
|
49
-26%
|
31
-37%
|
11
N/A
|
|
| Total Liabilities & Equity |
12
N/A
|
15
+26%
|
41
+172%
|
31
-25%
|
23
-26%
|
20
-15%
|
22
+11%
|
101
+363%
|
70
-30%
|
61
-14%
|
38
-37%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
10
|
13
|
22
|
28
|
28
|
31
|
34
|
47
|
47
|
47
|
47
|
|
Switch to:
Switch to:
See Also
Other Heidelberg Pharma AG listings:
Discover More
